Background of Neomycin

Neomycin is a widely used antibiotic belonging to the aminoglycoside group. It has garnered significant attention in the medical field for its efficacy in treating various conditions, particularly hepatic coma, perioperative prophylaxis, and constipation-predominant irritable bowel syndrome (IBS-C).

Browse all Neomycin products

Figure 1. Chemical structure of neomycin B.
(Source: Cui, W. et al., 2009)

Biosynthetic Pathway of Neomycin

The biosynthetic pathway of neomycin involves a series of enzymatic reactions within the bacterium Streptomyces fradiae. This pathway leads to the production of the complex structure of neomycin, consisting of two amino sugars, neamine and neobiosamine, connected by a glycosidic bond.

The biosynthesis of neomycin begins with the precursor molecule called D-glucosamine-6-phosphate. This precursor undergoes several enzymatic transformations, including amination, phosphorylation, and epimerization, to form the amino sugar neamine. Neamine serves as the core structure of neomycin and provides the foundation for further modifications.

Once neamine is formed, a series of enzymatic reactions occur to introduce additional functional groups and modifications. These reactions involve various enzymes, including transferases, methyltransferases, and glycosyltransferases. These enzymes catalyze the transfer of specific chemical groups, such as methyl groups and sugar moieties, to neamine, leading to the diversification of neomycin's structure.

One notable modification in the biosynthesis of neomycin is the attachment of a 2-deoxystreptamine (DOS) ring to neamine. This is achieved through the action of a specific transferase enzyme called neomycin synthase. The DOS ring is an essential component of neomycin's structure and contributes to its antibacterial activity.

The biosynthetic pathway also involves the generation of various sugar moieties, such as D-glucose, D-galactose, and N-acetylglucosamine, which are attached to neamine. These sugar moieties are introduced through the activity of glycosyltransferases, which transfer the appropriate sugars to specific positions on the neamine core.

Pharmacokinetics of Neomycin

Neomycin has unique pharmacokinetic properties that contribute to its effectiveness as an oral agent for suppressing intestinal bacterial flora.

• Absorption: Neomycin is not absorbed from the gastrointestinal (GI) tract, which makes it an ideal choice for oral administration. This lack of absorption allows neomycin to target and act directly on intestinal bacteria, without significant systemic effects.
• Distribution: When neomycin is administered orally, the amount absorbed and distributed to the tissues increases cumulatively with each dose, eventually reaching a steady-state concentration. The primary route of excretion for neomycin is through the kidneys, and the renal cortex contains the highest concentration of the drug. Additionally, with cumulative dosing, neomycin can progressively accumulate in the inner ear. After discontinuation of neomycin, the drug bound to tissues is slowly released over a period of several weeks.
• Metabolism: Due to its limited systemic absorption after administration, the metabolism process is considered negligible.
• Elimination: Approximately 97% of the oral dose of neomycin sulfate is excreted unchanged in feces. This means that the majority of the drug is eliminated from the body without undergoing significant metabolic changes.

Potential Side Effects

While neomycin is generally considered safe and well-tolerated when used as directed, it can have potential side effects, especially when used orally or systemically. Some common side effects include:

• Nephrotoxicity: Neomycin has the potential to cause kidney damage, particularly when used in high doses or for prolonged periods. Patients with pre-existing kidney problems are at a higher risk.
• Ototoxicity: Neomycin can cause damage to the inner ear, leading to hearing loss or balance problems. This side effect is usually associated with high systemic doses or prolonged use.
• Allergic Reactions: Some individuals may develop allergic reactions to neomycin, ranging from mild skin rashes to severe anaphylactic reactions.

Neomycin-Related Antibodies

Neomycin-Related Antigens

Neomycin-Related ELISA Kits